Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

NCT07403552 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ensho Therapeutics, Inc.